8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 23, 2014

Cigna Corporation

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation) 1-08323 (Commission File Number) 06-1059331 (IRS Employer Identification No.)

900 Cottage Grove Road

Bloomfield, Connecticut 06002

(Address of principal executive offices)  (Zip Code)

Registrant's telephone number, including area code:

(860) 226-6000

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d)  On April 23, 2014, the Board of Directors (the “Board”) of Cigna Corporation (“Cigna” or the “Company”) appointed Michelle Gass as an independent member of the Board, effective as of the same date.  Ms. Gass also will serve on the Audit Committee and the Corporate Governance Committee of the Board.

Ms. Gass will participate in Cigna’s non-employee director compensation program, as described on pages 28 through 30 of Cigna’s proxy statement for the 2014 annual meeting of shareholders filed with the Securities and Exchange Commission (the “SEC”) on March 14, 2014.  A description of the non-employee director compensation program also is contained in Exhibit 10.3 to Cigna's annual report on Form 10-K for the year ended December 31, 2011 filed with the SEC on February 23, 2012.

A copy of the Company’s press release announcing the appointment of Ms. Gass to the Board is attached to this report as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d)           Exhibits.

Exhibit No.	Description
99.1	Press release dated April 23, 2014.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Cigna Corporation
Date:  April 23, 2014	By:      /s/ Nicole S. Jones
	Nicole S. Jones
	Executive Vice President
	and General Counsel

Exhibit Index

Exhibit No.	Description
99.1	Press release dated April 23, 2014.

EX-99.1

Exhibit 99.1

NEWS RELEASE  

CONTACT:	Matt Asensio, Media Relations - Matthew.Asensio@cigna.com, 860-226-2599
	Ted Detrick, Investor Relations - Edwin.Detrick@cigna.com, 215-761-1414

Michelle Gass Appointed to Cigna Board of Directors

BLOOMFIELD, Conn. – April 23, 2014 – Cigna Corporation (NYSE:CI) today announced that Michelle Gass has been appointed to the Cigna Board of Directors, effective immediately, and will serve on the Board’s Corporate Governance and Audit Committees.

Ms. Gass, 46, is the Chief Customer Officer of Kohl’s Corporation with leadership responsibility for Kohl’s omni-channel platform, ecommerce business, and marketing, public relations, and branding strategies across all channels.  Prior to joining Kohl’s in June 2013, Ms. Gass spent more than 16 years with Starbucks Corporation in a variety of senior leadership roles which included leading the Europe and Middle East operations as President, Starbucks EMEA, as well as leading global strategy, marketing and category management during her tenure there.  Before Starbucks, Ms. Gass worked in marketing and new product development with The Procter & Gamble Company.

“We are delighted to have Michelle join the Board,” said David M. Cordani, Cigna President and Chief Executive Officer.  “Michelle’s experience at some of the world’s most successful consumer companies will be invaluable to Cigna as we continue to deliver more personalized products and services to our customers and clients in a highly dynamic environment.”

“Michelle’s global, customer-focused expertise will add tremendous value to the Cigna Board and will enhance the Corporation’s continued execution of its ‘Go Deep, Go Global, Go Individual’ strategy,” said Isaiah Harris, Jr., Cigna Chairman of the Board.

For more information on Cigna's Board of Directors, go to http://www.cigna.com/about-us/corporate-governance/.

About Cigna

Cigna Corporation (NYSE: CI) is a global health service company dedicated to helping people improve their health, well-being and sense of security. All products and services are provided exclusively through operating subsidiaries of Cigna Corporation, including Connecticut General Life Insurance Company, Cigna Health and Life Insurance Company, Life Insurance Company of North America, Cigna Life Insurance Company of New York and their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy and vision care benefits, and other related products including group disability, life, and accident coverage. Cigna has sales capability in over 30 countries and jurisdictions, with over 80 million customer relationships throughout the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com.